Pitas R E, Boyles J, Mahley R W, Bissell D M
J Cell Biol. 1985 Jan;100(1):103-17. doi: 10.1083/jcb.100.1.103.
Acetoacetylated (AcAc) and acetylated (Ac) low density lipoproteins (LDL) are rapidly cleared from the plasma (t1/2 approximately equal to 1 min). Because macrophages, Kupffer cells, and to a lesser extent, endothelial cells metabolize these modified lipoproteins in vitro, it was of interest to determine whether endothelial cells or macrophages could be responsible for the in vivo uptake of these lipoproteins. As previously reported, the liver is the predominant site of the uptake of AcAc LDL; however, we have found that the spleen, bone marrow, adrenal, and ovary also participate in this rapid clearance. A histological examination of tissue sections, undertaken after the administration of AcAc LDL or Ac LDL (labeled with either 125I or a fluorescent probe) to rats, dogs, or guinea pigs, was used to identify the specific cells binding and internalizing these lipoproteins in vivo. With both techniques, the sinusoidal endothelial cells of the liver, spleen, bone marrow, and adrenal were labeled. Less labeling was noted in the ovarian endothelia. Uptake of AcAc LDL by endothelial cells of the liver, spleen, and bone marrow was confirmed by transmission electron microscopy. These data suggest uptake through coated pits. Uptake of AcAc LDL was not observed in the endothelia of arteries (including the coronaries and aorta), veins, or capillaries of the heart, testes, kidney, brain, adipose tissue, and duodenum. Kupffer cells accounted for a maximum of 14% of the 125I-labeled AcAc LDL taken up by the liver. Isolated sinusoidal endothelial cells from the rat liver displayed saturable, high affinity binding of AcAc LDL (Kd = 2.5 X 10(-9) M at 4 degrees C), and were shown to degrade AcAc LDL 10 times more effectively than aortic endothelial cells. These data indicate that specific sinusoidal endothelial cells, not the macrophages of the reticuloendothelial system, are primarily responsible for the removal of these modified lipoproteins from the circulation in vivo.
乙酰乙酰化(AcAc)和乙酰化(Ac)的低密度脂蛋白(LDL)可迅速从血浆中清除(半衰期约为1分钟)。由于巨噬细胞、库普弗细胞以及程度较轻的内皮细胞在体外可代谢这些修饰的脂蛋白,因此确定内皮细胞或巨噬细胞是否可能是这些脂蛋白在体内摄取的原因很有意义。如先前报道,肝脏是摄取AcAc LDL的主要部位;然而,我们发现脾脏、骨髓、肾上腺和卵巢也参与了这种快速清除过程。在给大鼠、狗或豚鼠注射AcAc LDL或Ac LDL(用125I或荧光探针标记)后,对组织切片进行组织学检查,以确定体内结合并内化这些脂蛋白的特定细胞。使用这两种技术,肝脏、脾脏、骨髓和肾上腺的窦状内皮细胞都被标记。卵巢内皮中的标记较少。通过透射电子显微镜证实肝脏、脾脏和骨髓的内皮细胞摄取了AcAc LDL。这些数据表明是通过有被小窝摄取的。在动脉(包括冠状动脉和主动脉)、静脉或心脏、睾丸、肾脏、大脑、脂肪组织和十二指肠的毛细血管的内皮中未观察到AcAc LDL的摄取。库普弗细胞最多占肝脏摄取的125I标记的AcAc LDL的14%。从大鼠肝脏分离的窦状内皮细胞显示出对AcAc LDL的可饱和、高亲和力结合(4℃时Kd = 2.5×10^(-9) M),并且被证明降解AcAc LDL的效率比主动脉内皮细胞高10倍。这些数据表明,特定的窦状内皮细胞而非网状内皮系统的巨噬细胞,主要负责在体内从循环中清除这些修饰的脂蛋白。